Aim Biotech
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
747 Howard St, San Francisco, California...Phone Number
+65 67770246Website
www.aimbiotech.comRevenue
$5.8 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Aim Biotech
AIM Biotech specializes in developing human-relevant microphysiological systems (MPS) for predictive drug testing, focusing on non-animal models that enhance drug discovery. Their product offerings include advanced 3D tissue culture platforms such as idenTx and organiX, designed for scalable and flexible drug discovery applications. The company serves bio-pharmaceutical researchers and regulators globally, providing contract research services and custom assay development to accelerate drug development. AIM Biotech aims to revolutionize the drug discovery process by delivering clinically relevant results through innovative technology.Explore more
Aim Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aim Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Aim Biotech recently announced quarterly report
Click to see if Aim Biotech had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if Aim Biotech is spiking on competitors!
Check if Aim Biotech has recently received funding, and reach out quickly before it becomes old news!
Aim Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Aim Biotech
Product Launch: Get notified when Aim Biotech launches new products
Funding: Get notified immidiatlly once Aim Biotech has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Aim Biotech as Masked Content
Find 3 more new buyers
Compare Similar Companies to Aim Biotech
Compare insights from companies similar to Aim Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aim Biotech is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Aim Biotech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Aim Biotech.
Aim Biotech Tech Stack
A closer look at the technologies used by Aim Biotech
Aim Biotech News & Media
AIM Biotech Launches High-throughput Organ-on-a-chip System, The idenTx 40 Plate, to Recreate Human Microphysiology at Scale
Boston, Massachusetts and Singapore, Singapore--(Newsfile Corp. - November 17, 2021) - AIM Biotech has launched the idenTx 40 Plate, a high-throughput organ-on-a-chip system that lets researchers at biotechnology and pharmaceutical companies faithfully recreate the function of human organs and tissues without using animals for research. This empowers preclinical studies by delivering human-focused, clinically relevant results to better inform IND...AIM Biotech Launches Organ-on-a-Chip Contract Research Service
Singapore & Boston, Massachusetts--(Newsfile Corp. - March 2, 2021) - AIM Biotech has launched a contract research service, which uses its organ-on-a-chip technology to accelerate and improve drug discovery and development. AIM's 3D microfluidic organ-on-a-chip platform more accurately mimics the human microenvironment than conventional assays. As a result, drug discovery organizations can generate more predictive data and better inform their decisions ahead of clinical trials....AIM Completes Series A to Accelerate Growth of its Organ-on-a-Chip Business
Boston, Massachusetts and Singapore--(Newsfile Corp. - November 19, 2020) - AIM Biotech completed its series A financing to accelerate growth of its organ-on-a-chip business. The company's advanced research tool mimics human organs and disease models in the lab to improve, accelerate and reduce the cost of drug discovery for academic, translational and clinical researchers. The round was led by Wavemaker Partners and included participation...AIM Biotech Appoints Jim Mcgorry as CEO to Expand Its Organ-on-a-Chip Business
Boston, Massachusetts & Singapore, Singapore--(Newsfile Corp. - November 2, 2020) - AIM Biotech has appointed Jim McGorry as its Chief Executive Officer. Mr. McGorry was appointed to lead the expansion of AIM's proprietary organ-on-a-chip business. AIM's platform and world-class lab services let drug researchers get more relevant, human-focused data at every stage of development using the AIM chip. Mr. McGorry is a career executive...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Aim Biotech
Sign Up For FreeTo access detailed company insights
AIM Biotech specializes in developing human-relevant microphysiological systems (MPS) for predictive drug testing, focusing on non-animal models that enhance drug discovery. Their product offerings include advanced 3D tissue culture platforms such as idenTx and organiX, designed for scalable and flexible drug discovery applications. The company ser... Read More
